Related Experiment Video
Updated: Aug 9, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Role of the Notch1 signaling pathway in ischemic heart disease (Review)
Xiafeng Peng1, Shixin Wang1, Hongwu Chen1
1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Insights
Aberrant Notch1 signaling is common in ischemic heart disease (IHD). Targeting Notch1 may improve treatments for IHD patients by influencing cellular processes and repair mechanisms.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Cellular Biology
Background:
- Ischemic heart disease (IHD) involves atherosclerotic plaque development and rupture.
- The Notch signaling pathway is crucial for intercellular communication.
- Aberrant Notch1 signaling is consistently observed in IHD, indicating its clinical relevance.
Approach:
- This review summarizes Notch1 signaling's role in endothelial cells, vascular smooth muscle cells, and macrophages during IHD development.
- It examines Notch1's effects on IHD remodeling stages: reendothelialization, neovascularization, and myocardial fibrosis.
- The review discusses Notch1's involvement in reperfusion therapies and cardiac regeneration.
Key Points:
- Notch1 signaling impacts key cell types involved in IHD pathogenesis.
- Notch1 influences critical pathological processes like fibrosis and neovascularization.
- The pathway plays a role in both disease progression and therapeutic interventions.
Conclusions:
- Notch1 signaling is implicated in the development and progression of ischemic heart disease.
- Modulating Notch1 signaling presents a potential therapeutic strategy for IHD.
- Targeting Notch1 could enhance treatment efficacy for patients suffering from IHD.
Abstract:
Ischemic heart disease (IHD) is a prevalent cardiovascular disease characterized by the formation, progression and rupture of atherosclerotic plaque. The Notch signaling pathway is a key mechanism facilitating intercellular coordination. An increasing number of studies have revealed the significance of Notch signaling, particularly as regards Notch1. Of note, the existence of aberrant Notch1 signaling in IHD is universal, suggesting clinical significance. Thus, the present review summarizes the implications of Notch1 signaling in endothelial cells, vascular smooth muscle cells and macrophages in association with the development of IHD. The present review also examined the effects of Notch1 signaling on various remodeling stages of IHD consisting of reendothelialization, neovascularization, and myocardial fibrosis. Moreover, the participation of Notch1 signaling in conventional reperfusion treatments and cardiac regeneration therapies is discussed. On the whole, the present review aims to outline Notch1 signaling as a novel target which may be used to enhance the treatment efficacy for patients with IHD.
More Related Videos
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure II: Pathophysiology